Suppr超能文献

呃逆的烦恼:硬膜外类固醇注射后罕见不良反应病例报告。

The annoyance of singultus: a case report of a rare adverse effect after epidural steroid injection.

机构信息

Department of Anesthesiology and Pain Management, Cleveland Clinic, 9500 Euclid Avenue, C25, Cleveland, OH, 44195, USA.

Department of Anesthesiology, Stony Brook University Renaissance School of Medicine, 101 Nicolls Road, Health Sciences Center, Level 4, Stony Brook, NY, 11794, USA.

出版信息

BMC Anesthesiol. 2024 Aug 31;24(1):302. doi: 10.1186/s12871-024-02682-8.

Abstract

OBJECTIVE

Cervical epidural steroid injections (ESIs) can provide effective pain management for patients suffering from chronic neck pain due to various pathological changes of the cervical spine. There are several rare adverse effects reported from interventional pain procedures, including persistent hiccups ("singultus"). Based on a limited number of cases, we propose a modified treatment algorithm for this adverse outcome (Fig. 3).

CASE REPORT

Singultus has been documented as an adverse effect of interventional pain procedures, including epidural steroid, facet joint, and sacroiliac joint injections. We describe the case of a general contractor who presented to our clinic with chronic neck pain and central canal stenosis. The patient received an uncomplicated lumbar ESI in the past and was recommended for a cervical interlaminar ESI. After an uneventful C6-C7 interlaminar ESI with dexamethasone, 1% lidocaine, and normal saline the patient developed singultus. Baclofen was sent to his pharmacy, but this was unsuccessful at alleviating his hiccups. The patient was subsequently started on chlorpromazine and found relief from his symptomatology.

CONCLUSION

Persistent hiccups after ESI or interventional pain procedures can be treated with conservative measures and non-pharmacologic methods, with escalation to therapy with baclofen, gabapentin, pregabalin, metoclopramide, chlorpromazine, other antipsychotic or antidopaminergic agents, and possible dual or triple therapy if further indicated.

摘要

目的

颈椎硬膜外类固醇注射(ESI)可为患有各种颈椎病理改变导致的慢性颈痛患者提供有效的疼痛管理。介入性疼痛治疗中报告了几种罕见的不良反应,包括持续性呃逆(“打嗝”)。基于少数病例,我们提出了这种不良反应的改良治疗方案(图 3)。

病例报告

打嗝已被记录为介入性疼痛治疗的不良反应,包括硬膜外类固醇、关节突关节和骶髂关节注射。我们描述了一位总承包商的病例,他因慢性颈痛和中央椎管狭窄到我们诊所就诊。该患者过去曾接受过腰椎 ESI,且被建议接受颈椎椎间孔 ESI。在 C6-C7 椎间孔 ESI 中使用地塞米松、1%利多卡因和生理盐水后,患者出现打嗝。巴氯芬被送到他的药房,但未能缓解他的打嗝。随后,患者开始服用氯丙嗪,并从他的症状中得到缓解。

结论

ESI 或介入性疼痛治疗后持续性呃逆可采用保守措施和非药物方法治疗,如果进一步需要,可升级为巴氯芬、加巴喷丁、普瑞巴林、甲氧氯普胺、氯丙嗪、其他抗精神病药或抗多巴胺能药物,以及可能的双重或三重治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b48/11365228/c9472ea934e5/12871_2024_2682_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验